Allergan Swoops in and Bags Troubled Repros Therapeutics Post author:Sam Post published:December 11, 2017 Post category:BioPharma The deal is expected to close in the first quarter of 2018. Source: BioSpace You Might Also Like Celgene Bangs Out Deal Worth $775 Million for Kendall Square Startup Delinia January 25, 2017 Novartis AG Pushes A NASH Combo Into Late-Stage Development With A Little Help From Its Friend Allergan April 17, 2017 4 Drug Stocks With Major FDA Decisions Coming This Month April 2, 2017
Novartis AG Pushes A NASH Combo Into Late-Stage Development With A Little Help From Its Friend Allergan April 17, 2017
